Stay updated on COVID-19 Cardiovascular Manifestations Clinical Trial
Sign up to get notified when there's something new on the COVID-19 Cardiovascular Manifestations Clinical Trial page.

Latest updates to the COVID-19 Cardiovascular Manifestations Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.4.2 was added and the previous lapse in government funding notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check17 days agoChange DetectedAn NIH site-wide notice about government funding and operating status was added, and the platform revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check24 days agoChange DetectedThe page now shows a glossary and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new 'Revision: v3.4.0'. The older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check38 days agoChange DetectedUpdated page revision to v3.3.4 and removed v3.3.3; this appears to be an administrative metadata change with no impact on study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded a Locations section with Texas; removed the Texas Locations entry and the HHS Vulnerability Disclosure; updated page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page shows a minor revision from v3.3.1 to v3.3.2 with no substantive changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to COVID-19 Cardiovascular Manifestations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COVID-19 Cardiovascular Manifestations Clinical Trial page.